Polymerase chain reaction

Global Cancer Microbiome Sequencing Market Landscape 2023-2027: Decreasing Sequencing Costs, Rise in Research & Development - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 29, 2023
Health, Oncology, Pacific Biosciences, QIAGEN, Prevalence, Biotechnology, Cancer, Diagnosis, Breast, Research, OraSure Technologies, Biomarker, Lung, Death, Incidence, Investment, Polymerase chain reaction, Clifton Springs Hospital & Clinic, Growth, WHO, Geography, Eurofins Scientific, Skin, World Health Organization, Oxford Nanopore Technologies, Software, Antibiotics, Medical imaging, Pharmaceutical industry, Illumina

The global cancer microbiome sequencing market is poised for remarkable growth during the forecast period from 2023 to 2027.

Key Points: 
  • The global cancer microbiome sequencing market is poised for remarkable growth during the forecast period from 2023 to 2027.
  • Decreasing Sequencing Costs: The cost of microbiome sequencing is reducing, making it more accessible for research and clinical applications.
  • Rise in Research & Development: Increasing research efforts aimed at understanding the impact of microbiomes on cancer have propelled the market.
  • Conclusion: With the convergence of growing cancer incidences, increasing awareness of microbiome contributions, and research advancements in sequencing technologies, the global cancer microbiome sequencing market is set for substantial growth.

Singular Genomics Appoints Genomics Veteran Marcia Eisenberg, Ph.D., to Board of Directors

Retrieved on: 
Tuesday, August 8, 2023
Singular, DNA, Enterprise, National Institute of Environmental Health Sciences, University, Senior, Doctor of Philosophy, State University of New York Upstate Medical University, Genomics, Health care, Biotechnology, NGS, State university system, LH, Lead, OMIC, Molecular biology, Fierce, Polymerase chain reaction, SAN, Medicine, Growth, Federal Bureau of Investigation, Health, Labcorp, Woman, NYSE, PCR, Management, Psychology, Biology

SAN DIEGO, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced the appointment of Marcia Eisenberg, Ph.D., to the Company’s Board of Directors.

Key Points: 
  • SAN DIEGO, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced the appointment of Marcia Eisenberg, Ph.D., to the Company’s Board of Directors.
  • “Marcia’s deep and diverse genomics expertise will be an asset to Singular as we drive our business strategy forward, and we are delighted to welcome her to the Board of Directors,” said Drew Spaventa, Chairman and Chief Executive Officer of Singular Genomics.
  • She served in a variety of other roles at Labcorp and its affiliates starting in 1990.
  • “I have been impressed by Singular Genomics’ growth and progress in launching a sequencing platform that I believe is uniquely positioned to positively impact many critical applications,” said Dr. Eisenberg.

QIAGEN receives FDA approval for companion diagnostic to Blueprint Medicines’ AYVAKIT® (avapritinib) in gastrointestinal stromal tumors

Retrieved on: 
Monday, August 7, 2023
TKI, GIST, DNA, QIAGEN, QGEN, Stromal cell, Gastrointestinal tract, DSM-IV codes, Research fellow, Biotechnology, NGS, Mutation, Helix, Sarcoma, PDGFRA, Patient, Physician, Polymerase chain reaction, Medicine, Nested polymerase chain reaction, MDX, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, NYSE, PCR, Food, Vaccine

The kit is the first platelet-derived growth factor receptor alpha (PDGFRA) assay to receive FDA approval as a companion diagnostic.

Key Points: 
  • The kit is the first platelet-derived growth factor receptor alpha (PDGFRA) assay to receive FDA approval as a companion diagnostic.
  • QIAGEN and Blueprint Medicines collaboratively developed the PDGFRA companion diagnostic assay.
  • QIAGEN is a pioneer in precision medicine and the leader in collaborating with pharmaceutical and biotechnology companies to develop companion diagnostics.
  • Furthermore, QIAGEN has recently announced a series of collaborations with Neuron23 and Helix to develop companion diagnostics in disease areas outside oncology.

$6.5+ Billion MRD (Minimal Residual Disease) Testing Market - Global and Regional Analysis and Forecasts to 2033 - Revolutionary Technologies Transform MRD Testing Market for Cancer Patients - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 20, 2023
Biotechnology, Health, Oncology, Lymphoma, DNA, Quest Diagnostics, Circulating tumor DNA, Partnership, Takeda, Health care, Hospital, Throttle position sensor, NGS, Integrated DNA Technologies, Bone marrow, Cancer, Research, Karyotype, MRD, Incidence, Patient, Polymerase chain reaction, Flow cytometry, Archery, Medicare, SNV, Growth, Region, Neoplasm, Leukemia, Integration, Recurrence, Benchmarking, PCR, Disease, Video game, Pharmaceutical industry, Medical imaging, Medical device

The global MRD testing market is projected to reach $6.67 billion by 2033 from $1.47 billion in 2022, growing at a CAGR of 14.81% during the forecast period 2023-2033.

Key Points: 
  • The global MRD testing market is projected to reach $6.67 billion by 2033 from $1.47 billion in 2022, growing at a CAGR of 14.81% during the forecast period 2023-2033.
  • The MRD testing market is driven by several factors, including the expansion in medicare coverage for MRD testing and the administration of solid tumor diagnosis.
  • The global MRD testing market is led by flow cytometry in the technology segment, with a 41.14% share in 2022.
  • Other end users, such as outpatient clinics and cancer clinics, also contribute significantly to the global MRD testing market.

Introducing the Anbio LAMP Solution: A Small, Yet Powerful Handheld Analyzer for Rapid, Point-of-Care Testing

Retrieved on: 
Wednesday, July 19, 2023
Fluorescence, DNA, Polymerase chain reaction, POC, Infection, PCR, RNA, GameChanger, LAMP, OTC, Vaccine

Anbio's LAMP Solution, or Loop-Mediated Isothermal Amplification, is a diagnostic technique used to amplify and detect specific DNA or RNA sequences.

Key Points: 
  • Anbio's LAMP Solution, or Loop-Mediated Isothermal Amplification, is a diagnostic technique used to amplify and detect specific DNA or RNA sequences.
  • Anbio's LAMP solution has high specificity, sensitivity, and fast results, perfect for over-the-counter (OTC) and point-of-care (POC) diagnostics.
  • "The Anbio LAMP Solution is a gamechanger in the POC and OTC space," said Krystal Tu, Global Marketing Director at Anbio.
  • To learn more about the LAMP Solution and Anbio's range of innovative diagnostic Solutions, please visit www.anbio.com .

Inflammatix Appoints Heiner Dreismann as New Board Member

Retrieved on: 
Monday, July 10, 2023
Molecular biology, Genetics, Doctor of Philosophy, Sepsis, Patient, Polymerase chain reaction, Host, Entrepreneurship, PCR, Management, MD

BURLINGAME, Calif., July 10, 2023 /PRNewswire/ -- Inflammatix, a pioneering molecular diagnostics company, announced today the appointment of Heiner Dreismann, PhD, as a member of the company's board of directors.

Key Points: 
  • BURLINGAME, Calif., July 10, 2023 /PRNewswire/ -- Inflammatix, a pioneering molecular diagnostics company, announced today the appointment of Heiner Dreismann, PhD, as a member of the company's board of directors.
  • Inflammatix appoints former Roche Molecular Systems CEO Heiner Dreismann, PhD, to its Board of Directors.
  • Besides Inflammatix, Dr. Dreismann currently serves on several boards of public, private, and non-profit organizations.
  • Dr. Dreismann commented, "I am so impressed by the Inflammatix approach of immune-based diagnostics, and with the extensive data published to date.

Revive Therapeutics Announces Results of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

Retrieved on: 
Thursday, July 6, 2023
CSE, Probability, Therapy, DSMB, Post, Hospital, Fever, COVID-19, SARS, Research, Disorder, Cough, Data monitoring committee, RVV, Patient, Polymerase chain reaction, Viral load, Heart rate, Death, Study, Safety, Pharmaceutical industry, Bucillamine

Although the number of hospitalization events was small, it demonstrated a positive trend in the Post-dose selection phase of the Study.

Key Points: 
  • Although the number of hospitalization events was small, it demonstrated a positive trend in the Post-dose selection phase of the Study.
  • There was no significant overall improvement trend between the Bucillamine and placebo arms for observed clinical symptoms and viral load data.
  • Additional analyses of the Study data are ongoing, which could support certain strategic decisions on pursuing the development and commercialization of Bucillamine.
  • There can be no assurance that the Company will proceed with the clinical development and regulatory approvals of Bucillamine for COVID-19 in the U.S. and internationally.

Global Forensic Technologies Market Report 2023: Sector is Expected to Reach $41.92 Billion by 2030 at a CAGR of 12.28% - ResearchAndMarkets.com

Retrieved on: 
Tuesday, June 20, 2023
Health, Biotechnology, Capillary electrophoresis, DNA, Homicide, United Nations, Law enforcement, Polymerase, Pharmacogenomics, Biodefense, MEA, Research, USD, Computer forensics, RTLS, Test management, Developed country, United, Robbery, Assault, Murder, Plant growth analysis, Judiciary, Knowledge, Growth, Polymerase chain reaction, LIMS, Digital, Massive parallel sequencing, PCR, Audit, Drug, Application, Location

The global forensic technologies market is witnessing significant growth due to advancements in technology and increasing demand for accurate crime investigation tools.

Key Points: 
  • The global forensic technologies market is witnessing significant growth due to advancements in technology and increasing demand for accurate crime investigation tools.
  • The market is expected to continue its upward trajectory, driven by the rising need for effective forensic solutions worldwide.
  • The Global Forensic Technologies market is segmented based on Product, Application, Service, Location, Techniques, and Region.
  • The global market for forensic technologies is witnessing a significant emphasis on two areas: portable forensics and laboratory forensics.

Global Analytical Instrumentation Market to 2030 - Increasing Adoption of Analytical Instrumentation for Precision Medicine Applications Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 15, 2023
Medical Devices, Health, Vaccine, Drug development, Thalassemia, Diabetes, Roche, COVID-19, Clinical trial, Microplastics, Research, COVID-19 testing, Government, Acquisition, Polymerase chain reaction, Agilent Technologies, Medicine, Conference, PCR, HPLC, Glycated hemoglobin, Fine chemical, Pharmaceutical industry, Retail

Analytical laboratory instrumentation includes a broad range of instruments with the main purpose of quantitative and qualitative analysis of samples.

Key Points: 
  • Analytical laboratory instrumentation includes a broad range of instruments with the main purpose of quantitative and qualitative analysis of samples.
  • Increasing research and development activities in the pharmaceutical and biotechnology industries and increasing adoption of analytical instrumentation for applications in precision medicine are key factors driving the industry.
  • Governments from various countries are continuously investing in pharmaceutical R&D to support new drug development and improve healthcare in their regions.
  • Moreover, technological advancements are also leading to a reduction in analysis time and are increasing the medical applications of analytical instrumentation.

Agricultural Testing Market worth $9.8 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, June 6, 2023
Tradition, Legionella, Marketing, Farmer, Fertilizer, Food safety, Biosolids, Pesticide, Soil, Risk, Bureau Veritas, Region, Cereal, ALS, Reagent, Microbial contamination of diesel fuel, Human, Rotation, Water, GMO, Toxicity, Research, USD, ELISA, GM, Polymerase chain reaction, Growth, PCR, Poultry, Seed, GAP, SGS, AsureQuality Limited, Agriculture, Maize, Meat, Food, Water quality, Nutrient, ALS Limited, Genetically modified organism, Microbial inoculant, Salmonella, Speciality chemicals, Vibrio, Solid, Intertek, Clostridium, Seafood, Atmosphere of Earth

The safety testing in application segment accounted for the largest share of the agricultural testing market in 2023 in terms of value.

Key Points: 
  • The safety testing in application segment accounted for the largest share of the agricultural testing market in 2023 in terms of value.
  • Safety testing of agricultural samples includes testing for targets such as toxins, pathogens, heavy metals, pesticides, GMOs, and organic contaminants.
  • The rapid technology of the technology segment accounted for the highest share of the agricultural testing market in 2023 to 2028 in terms of value.
  • The Asia Pacific region accounted for the fastest growing market, in terms of value, of the global agricultural testing market in 2028.